Green endoscopy, one step toward a sustainable future: Literature review

Endoscopy International Open, Journal Year: 2024, Volume and Issue: 12(08), P. E968 - E980

Published: July 15, 2024

Rapid climate change or crisis is one of the most serious emergencies 21st century, accounting for highly impactful and irreversible changes worldwide. Climate can also affect epidemiology disease burden gastrointestinal diseases because they have a connection with environmental factors nutrition. Gastrointestinal endoscopy intensive procedure significant contribution to greenhouse gas (GHG) emissions. Moreover, third highest generator waste in healthcare facilities contributions carbon footprint. The main sources direct emission are use high-powered consumption devices (e.g. computers, anesthesia machines, wash machines reprocessing, scope processors, lighting) production derived mainly from disposable devices. Indirect emissions those heating cooling facilities, processing histological samples, transportation patients materials. Consequently, sustainable been focus discussions between providers professional societies aim taking action reduce impact. term "green endoscopy" refers practice gastroenterology that aims raise awareness, assess, endoscopy´s Nevertheless, while awareness has growing, guidance about practical interventions footprint lacking. This review summarize current data regarding impact on GHG possible strategies mitigate this phenomenon. Further, we promote evolution more endoscopy".

Language: Английский

---

A survey of emergency medicine physicians’ knowledge, attitude, and practice towards esophagogastric variceal bleeding

International Journal of Emergency Medicine, Journal Year: 2025, Volume and Issue: 18(1)

Published: March 13, 2025

Esophageal-gastric variceal bleeding (EVB) is one of the leading causes mortality in patients with cirrhotic portal hypertension. Rapid, accurate, and effective emergency care crucial for successful patient outcomes. This study aims to evaluate knowledge, attitudes, practices Chinese physicians regarding EVB, goal improving diagnosis treatment gastrointestinal settings. A self-designed questionnaire based on clinical guidelines was developed assess EVB treating EVB. An online survey conducted among nationwide. Data were analyzed using descriptive statistics correlation analysis. The knowledge score 11.2 ± 3.5 (total 22), indicating a relatively low level understanding. Statistically significant differences scores observed across hospital grades, educational backgrounds, years experience, professional titles, participation relevant training programs (P < 0.05). mean attitude above 4 5), reflecting generally positive physicians. In terms practices, behavior 2.7 1.2, positively correlated demonstrate about treatment, although their attitudes remain positive. Their management are also insufficient. Enhancing education standardizing protocols necessary improve

Language: Английский

---

Development and validation of an integrated model for the diagnosis of liver cirrhosis with portal vein thrombosis combined with endoscopic characters and blood biochemistry data: a retrospective propensity score matching (PSM) cohort study

Annals of Medicine, Journal Year: 2025, Volume and Issue: 57(1)

Published: Jan. 29, 2025

Background Liver cirrhosis complicated by portal vein thrombosis (PVT) is a fatal complication with no specific manifestations but often misdiagnosed, it crucially increases the mortality worldwide. This study aimed to identify risk factors and establish predictive model for diagnosis of venous clinical routine blood tests endoscopic characteristics.

Language: Английский

---

Comparative efficacy of pre-emptive TIPS and elective TIPS in EGVB patients with cirrhosis: A single-center retrospective study

Saudi Journal of Gastroenterology, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 7, 2025

Abstract Background: Transjugular intrahepatic portosystemic shunt (TIPS) is the main method to prevent rebleeding of esophagogastric varices. Many studies have demonstrated that pre-emptive TIPS (p-TIPS) superior medicine combined with endoscopic standard therapy in efficacy high-risk patients, but very few relevant reported whether p-TIPS more effective than elective TIPS. This study aims compare and prognosis for treatment variceal bleeding (EGVB) patients cirrhosis. Methods: In this retrospective study, clinical data 92 cirrhosis who accepted after EGVB were collected. According different times TIPS, divided into group group. The following information documented: manifestations laboratory examination at 1, 3, 6 months operation, survival state, rates weeks months, postoperative complications serious adverse events during follow-up. Results: Child-Pugh score ( P = 0.002) MELD 0.006) significantly lower those th month treatment. rate no gastric coronary vein embolization was higher 0.034). hospitalized days < 0.001) costs No significant differences observed between two groups concerning rebleeding, overt hepatic encephalopathy, ascites, complications, events, occurrence. Conclusion: contributes liver function recovery enhances patient benefits 6-months postoperation compared without increasing incidence events.

Language: Английский

---

Endoscopic View of Common Gastrointestinal Diseases in Children

Indian Pediatrics Case Reports, Journal Year: 2025, Volume and Issue: 5(1), P. 55 - 59

Published: Jan. 1, 2025

Language: Английский

---

Endoscopic Ultrasound: Liver Biopsy and Portal Pressure Measurement

Current Hepatology Reports, Journal Year: 2025, Volume and Issue: 24(1)

Published: March 3, 2025

Language: Английский

---

The latest recommendations in the prophylaxis and treatment of bleeding from esophagogastric varices

Acta Facultatis Medicae Naissensis, Journal Year: 2025, Volume and Issue: 42(1), P. 27 - 41

Published: Jan. 1, 2025

Introduction/Aim. Esophagogastric varices develop in 50-60% of patients with liver cirrhosis, and 30% them have one episode variceal hemorrhage within two years diagnosis. The aim the paper was to present latest attitudes treatment esophagogastric varices. Literature review. Prevention first bleeding from esophageal (EV) involves use non-selective beta blockers (NSBB) or carvedilol, while case their intolerance contraindications for use, endoscopic band ligation (EBL) should be performed. In acute bleeding, endoscopy performed, preferably 12 hours presentation EBL applied. refractory (about 20%), repeated hemostasis balloon tamponade, self-expanding metal stent (SEMS), transjugular intrahepatic portosystemic shunt (TIPS) surgical therapy are required. Bleeding gastric (GV) is less common than EV but significantly more severe higher mortality frequent failure. choice application cyanoacrylate (CYA), which can applied under ultrasonography (EUS) control. trial administration coil injections without CYA. secondary prophylaxis EV, NSBB used combination EBL. cardiofundal varices, approach individual. Conclusion. primary prevention NSBB, combined (NSBB EBL) bleeding. CYA GI Refractory requires many therapeutic modalities.

Language: Английский

---

The Real-World Prevalence of Esophagogastric Varices, Bleeding, Emergency Room Visits, and Hospitalization Among Patients with Advanced Hepatocellular Carcinoma in the United States: A Retrospective Cohort Study

Journal of Hepatocellular Carcinoma, Journal Year: 2025, Volume and Issue: Volume 12, P. 961 - 972

Published: May 1, 2025

Language: Английский

---

The Prediction and Treatment of Bleeding Esophageal Varices in the Artificial Intelligence Era: A Review

Cureus, Journal Year: 2024, Volume and Issue: unknown

Published: March 8, 2024

Esophageal varices (EVs), a significant complication of cirrhosis, present considerable challenge in clinical practice due to their high risk bleeding and associated morbidity mortality. This manuscript explores the transformative role artificial intelligence (AI) management EV, particularly enhancing diagnostic accuracy predicting risks. It underscores potential AI offering noninvasive, efficient alternatives traditional methods such as esophagogastroduodenoscopy (EGD). The complexity EV is highlighted, necessitating multidisciplinary approach that includes pharmacological therapy, endoscopic interventions, and, some cases, surgical options tailored individual patient profiles. Additionally, paper emphasizes importance integrating into medical education practice, preparing healthcare professionals for evolving landscape technology. projects future where significantly influences gastrointestinal bleeding, improving decision-making, outcomes, overall efficiency. study advocates patient-centered healthcare, balancing incorporation innovative technologies with ethical principles diverse needs patients optimize treatment efficacy enhance accessibility.

Language: Английский

---

Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus‐related liver cirrhosis

Hepatology Research, Journal Year: 2024, Volume and Issue: unknown

Published: June 5, 2024

Abstract Aim Esophagogastric varices (EGV) are a serious complication of hepatitis C virus (HCV)‐related liver cirrhosis (HCV‐LC). In most cases, portal hypertension improves after sustained virologic response (SVR) is achieved with direct‐acting antiviral (DAA) treatment; however, in some EGV exacerbation occurs HCV elimination. We investigated whether von Willebrand factor (VWF) and disintegrin‐like metalloproteinase thrombospondin type‐1 motif 13 (ADAMTS13) can predict progression HCV‐LC SVR achievement. Methods This retrospective study enrolled 47 patients who an DAA treatment. Eighteen experienced the was (EGV group). Twenty‐nine did not experience (non‐EGV Plasma VWF antigen levels ADAMTS13 activity were measured day before Results The group had significantly higher plasma ( p = 0.00331) VWF‐to‐ADAMTS13 ratios 0.000249) than non‐EGV group. Multivariate logistic regression models found that ratio >2.3 only risk for (hazard [HR], 18.4; 95% confidence interval [CI], 3.08–109; 0.00138). During observation period, cumulative incidence achievement ≤2.3 (HR, 6.4; CI, 1.78–22.96; 0.0044). Conclusions treatment could

Language: Английский

---